The variable sensitivity of HIV Ag/Ab combination assays in the detection of p24Ag according to genotype could compromise the diagnosis of early HIV infection

Journal of Clinical Virology

Volumn 55, Issue 2, 2012, Pages 121-127

  Ly, Thoai Duong ^a   Plantier, Jean Christophe ^b   Leballais, Lionel ^c   Gonzalo, Sylvie ^d   Lemée, Véronique ^b   Laperche, Syria ^c  

^a Biomnis Laboratory   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

^c INSTITUT NATIONAL DE LA TRANSFUSION SANGUINE   (France)

^d Biomnis Laboratory   (France)

Author keywords

HIV combined antigen and antibody detection; HIV subtypes; P24Ag

Indexed keywords

ANTIGEN P24;

ANTIGEN ANTIBODY REACTION; ANTIGEN DETECTION; ARTICLE; CELL CULTURE; EARLY DIAGNOSIS; GENOTYPE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LIMIT OF DETECTION; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; VIRUS ISOLATION;

FRANCE; GENOTYPE; HIV ANTIBODIES; HIV CORE PROTEIN P24; HIV INFECTIONS; HIV-1; HIV-2; SENSITIVITY AND SPECIFICITY;

EID: 84865179130     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2012.06.012     Document Type: Article

References (41)

1. Taylor B.S., Sobieszczyk M.E., McCutchan F.E., Hammer S.M. The challenge of HIV-1 subtype diversity. N Engl J Med 2008, 358:1590-1602.
2. Gurtler L.G., Hauser P.H., Eberle J., von Brunn A., Knapp S., Zekeng L., et al. A new subtype of human immunodeficiency virus type 1 (MVP-5180) from Cameroon. J Virol 1994, 68:1581-1585.
3. Simon F., Mauclere P., Roques P., Loussert-Ajaka I., Muller-Trutwin M.C., Saragosti S., et al. Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat Med 1998, 4:1032-1037.
4. Plantier J.C., Leoz M., Dickerson J.E., De Oliveira F., Cordonnier F., Lemee V., et al. A new human immunodeficiency virus derived from gorillas. Nat Med 2009, 15:871-872.
5. Roques P., Robertson D.L., Souquiere S., Apetrei C., Nerrienet E., Barre-Sinoussi F., et al. Phylogenetic characteristics of three new HIV-1 N strains and implications for the origin of group N. AIDS 2004, 18:1371-1381.
6. Depatureaux A., Charpentier C., Leoz M., Unal G., Damond F., Kfutwah A., et al. Impact of HIV-1 group O genetic diversity on genotypic resistance interpretation by algorithms designed for HIV-1 group M. J Acquir Immune Defic Syndr 2011, 56:139-145.
7. Tuaillon E., Gueudin M., Lemee V., Gueit I., Roques P., Corrigan G.E., et al. Phenotypic susceptibility to nonnucleoside inhibitors of virion-associated reverse transcriptase from different HIV types and groups. J Acquir Immune Defic Syndr 2004, 37:1543-1549.
8. Plantier J.C., Djemai M., Lemee V., Reggiani A., Leoz M., Burc L., et al. Census and analysis of persistent false-negative results in serological diagnosis of human immunodeficiency virus type 1 group O infections. J Clin Microbiol 2009, 47:2906-2911.
9. Gautheret-Dejean A., Mesmin-Poho S., Birguel J., Lemee V., Huraux J.M., Plantier J.C. Unequal detection of HIV type 1 group O infection by simple rapid tests. Clin Infect Dis 2008, 46:1936-1937.
10. Laforgerie E., Boucher B., Ly T.D., Maisoneuve L., Izopet J., Delaugerre C., et al. Sensitivity of 8 CE (European Community)-approved rapid disposable tests for anti-HIV antibody detection during and after seroconversion. J Virol Methods 2010, 165:105-107.
11. Pavie J., Rachline A., Loze B., Niedbalski L., Delaugerre C., Laforgerie E., et al. Sensitivity of five rapid HIV tests on oral fluid or finger-stick whole blood: a real-time comparison in a healthcare setting. PLoS One 2010, 5:e11581.
12. Apetrei C., Loussert-Ajaka I., Descamps D., Damond F., Saragosti S., Brun-Vezinet F., et al. Lack of screening test sensitivity during HIV-1 non-subtype B seroconversions. AIDS 1996, 10:F57-F60.
13. Loussert-Ajaka I., Ly T.D., Chaix M.L., Ingrand D., Saragosti S., Courouce A.M., et al. HIV-1/HIV-2 seronegativity in HIV-1 subtype O infected patients. Lancet 1994, 343:1393-1394.
14. Gaudy C., Moreau A., Brunet S., Descamps J.M., Deleplanque P., Brand D., et al. human immunodeficiency virus (HIV) type 1 mutant that escapes detection in a fourth-generation immunoassay for HIV infection. J Clin Microbiol 2004, 42:2847-2849.
15. Zouhair S., Roussin-Bretagne S., Moreau A., Brunet S., Laperche S., Maniez M., et al. Group o human immunodeficiency virus type 1 infection that escaped detection in two immmunoassays. J Clin Microbiol 2006, 44:662-665.
16. Gueudin M., Plantier J.C., Lemee V., Schmitt M.P., Chartier L., Bourlet T., et al. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J Acquir Immune Defic Syndr 2007, 44:500-505.
17. Foglieni B., Candotti D., Guarnori I., Raffaele L., Berzuini A., Spreafico M., et al. A cluster of human immunodeficiency virus Type 1 recombinant form escaping detection by commercial genomic amplification assays. Transfusion 2011, 51:719-730.
18. Gueudin M., Leoz M., Lemee V., De Oliveira F., Vessiere A., Kfutwah A., et al. A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection. J Clin Microbiol 2012, 50:831-836.
19. Sire J.M., Vray M., Merzouk M., Plantier J.C., Pavie J., Maylin S., et al. Comparative RNA quantification of HIV-1 group M and non-M with the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2.0 and Abbott Real-Time HIV-1 PCR assays. J Acquir Immune Defic Syndr 2011, 56:239-243.
20. Wirden M., Tubiana R., Fourati S., Thevenin M., Simon A., Canestri A., et al. Upgraded Cobas Ampliprep-Cobas TaqMan version 2.0 HIV-1 RNA quantification assay versus first version: correction of underestimations. J Clin Microbiol 2011, 49:2700-2702.
21. COMMISSION DECISION of 3 February 2009 amending Decision 2002/364/EC on common technical specifications for in vitro-diagnostic medical devices. Official Journal of the European Union. 2009;L39/4.
22. Ly T.D., Ebel A., Faucher V., Fihman V., Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?. J Virol Methods 2007, 143:86-94.
23. Weber B., Berger A., Rabenau H., Doerr H.W. Evaluation of a new combined antigen and antibody human immunodeficiency virus screening assay, VIDAS HIV DUO Ultra. J Clin Microbiol 2002, 40:1420-1426.
24. Ly T.D., Laperche S., Courouce A.M. Early detection of human immunodeficiency virus infection using third- and fourth-generation screening assays. Eur J Clin Microbiol Infect Dis 2001, 20:104-110.
25. Weber B. HIV seroconversion: performance of combined antigen/antibody assays. AIDS 2003, 17:931-933.
26. Ly T.D., Edlinger C., Vabret A. Contribution of combined detection assays of p24 antigen and anti-human immunodeficiency virus (HIV) antibodies in diagnosis of primary HIV infection by routine testing. J Clin Microbiol 2000, 38:2459-2461.
27. Ly T.D., Laperche S., Brennan C., Vallari A., Ebel A., Hunt J., et al. Evaluation of the sensitivity and specificity of six HIV combined p24 antigen and antibody assays. J Virol Methods 2004, 122:185-194.
28. Miedouge M., Greze M., Bailly A., Izopet J. Analytical sensitivity of four HIV combined antigen/antibody assays using the p24 WHO standard. J Clin Virol 2011, 50:57-60.
29. Manak M., Sina S., Anekella B., Hewlett I., Sanders-Buell E.E., Ragupathy V., et al. Pilot studies for development of an HIV subtype panel for surveillance of global diversity. AIDS Res Hum Retroviruses 2012, 28:594-606.
30. Sickinger E., Jonas G., Yem A.W., Goller A., Stieler M., Brennan C., et al. Performance evaluation of the new fully automated human immunodeficiency virus antigen-antibody combination assay designed for blood screening. Transfusion 2008, 48:584-593.
31. Sickinger E., Stieler M., Kaufman B., Kapprell H.P., West D., Sandridge A., et al. Multicenter evaluation of a new, automated enzyme-linked immunoassay for detection of human immunodeficiency virus-specific antibodies and antigen. J Clin Microbiol 2004, 42:21-29.
32. Maniez M., Rouzioux C., Couroucé A.M. Evaluation des trousses de dépistage de l'antigène p24 du VIH. Spectra Biol 1997, 16:41-49.
33. Brennan C.A., Yamaguchi J., Devare S.G., Foster G.A., Stramer S.L. Expanded evaluation of blood donors in the United States for human immunodeficiency virus type 1 non-B subtypes and antiretroviral drug-resistant strains: 2005 through 2007. Transfusion 2010, 50:2707-2712.
34. Delwart E., Slikas E., Stramer S.L., Kamel H., Kessler D., Krysztof D., et al. Genetic diversity of recently acquired and prevalent HIV, hepatitis B virus, and hepatitis C virus infections in US blood donors. J Infect Dis 2012, 205:875-885.
35. Leoz M., Chaix M.L., Delaugerre C., Rivoisy C., Meyer L., Rouzioux C., et al. Circulation of multiple patterns of unique recombinant forms B/CRF02_AG in France: precursor signs of the emergence of an upcoming CRF B/02. AIDS 2011, 25:1371-1377.
36. Descamps D., Chaix M.L., Montes B., Pakianather S., Charpentier C., Storto A., et al. Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France. J Antimicrob Chemother 2010, 65:2620-2627.
37. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 2006, 20:W13-W23.
38. Frange P., Galimand J., Vidal N., Goujard C., Deveau C., Souala F., et al. New and old complex recombinant HIV-1 strains among patients with primary infection in 1996-2006 in France: the French ANRS CO06 primo cohort study. Retrovirology 2008, 5:69.
39. Galimand J., Frange P., Rouzioux C., Deveau C., Avettand-Fenoel V., Ghosn J., et al. Short communication: evidence of HIV type 1 complex and second generation recombinant strains among patients infected in 1997-2007 in France: ANRS CO06 PRIMO Cohort. AIDS Res Hum Retroviruses 2010, 26:645-651.
40. Vessiere A., Leoz M., Brodard V., Strady C., Lemee V., Depatureaux A., et al. First evidence of a HIV-1 M/O recombinant form circulating outside Cameroon. AIDS 2010, 24:1079-1082.
41. Delaugerre C., De Oliveira F., Lascoux-Combe C., Plantier J.C., Simon F. HIV-1 group N: travelling beyond Cameroon. Lancet 2011, 378:1894.